Early Development Workshop


Efficient early clinical drug development


Innovative and adaptive approaches
built out from mechanism-of-action


RSVP by September 27, 2018 | 10:00 - 15:00

Event Details

D'Angleterre Copenhagen


Come meet the experts:Ewoud-Jan van Hoogdalem, PRA Health Sciences; Mads Almose Røpke, Leo Pharma; Martin Bonde, Vaccibody; Iftekhar Khan, MHRA; Suzanne Pihl, Ascendis;  Nils Piwon, and Jo Hulbert, PRA Health Sciences as we share perspectives in deciding the best early clinical development strategy based on mechanism of action, using adaptive & innovative designs. Discussions include rational use of biomarkers in the translational medicine mindset, tailored therapy, and drug evaluation.




Registration is now closed. 

If you have any questions, please email gelovichmary@prahs.com.

Still have questions?

We'd love to speak with you and answer any questions you have. Please reach out at GelovichMary@prahs.com